Panacea Acquisition Corp. II Announces Pricing of $150,000,000 Initial Public Offering
SAN FRANCISCO, CA, April 06, 2021 (GLOBE NEWSWIRE) -- Panacea Acquisition Corp. II (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition,...
Panacea Announces Effectiveness of Registration Statement for Proposed Business Combination with Nuvation Bio
Panacea Acquisition Corp., a Delaware corporation (the “Company”) (NYSE: PANA.U, PANA, PANA WS), announced today that its registration statement on Form S-4 (File No. 333-250036) (as amended, the “Registration...
SPACs Surge as Biotech Booms
NetworkNewsWire Editorial Coverage : As the world has focused on the search for COVID vaccines and therapeutics, biotech IPOs have quietly gone bonkers . As a matter of fact, 2020 is on track to post...